Renrenkang Pharmaceutical

Guangdong Renrenkang Pharmaceutical Co., Ltd. was founded in 1993. It is a Hong Kong-funded wholly-owned modern high-tech enterprise specializing in drug research, development, production, and sales. The company's production base is located in Zhuhai City, equipped with state-of-the-art production lines that have successfully passed the new GMP certification.
The company has established extensive cooperative relationships with numerous domestic and international universities and research institutions, attracting a large number of outstanding pharmaceutical talents. It boasts a team of senior and mid-level pharmaceutical engineers, licensed pharmacists, and various professional technical personnel, as well as advanced production equipment and pharmaceutical manufacturing processes. It has multiple production lines for dosage forms such as tablets, capsules, creams, and active pharmaceutical ingredients (APIs). Meanwhile, it holds an innovative leading position in specialized therapeutic areas including respiratory, dermatology, rheumatology and orthopedics, and digestive systems.
The company inherits the core essence of pharmaceutical industry technology, integrates modern high-tech, and has formed several well-known products under its corporate brand "Renrenkang", including "Qianbai", "Yiweishi", and "Qingqing". Among them, the birth of the exclusively proprietary medical insurance product, hydroquinone cream (trade name: Qianbai), has filled the gap in the domestic pharmaceutical market for freckle removal and treatment.
In the future, Renrenkang will strive to create a marketing pattern of "big products, big market", actively expand hospital and OTC markets, leverage core product advantages, highlight the strength of marketing alliances, strengthen service management levels, enhance development momentum, and achieve innovative development.